IPO TABLE: Neothetics launches; Juno, Bellicum seek big bucks; EyeGate cuts price range
This article was originally published in Scrip
Executive Summary
The only drug developer to launch an initial public offering during the week of 17 to 21 November was Neothetics, a San Diego-based company targeting belly fat, but two new IPOs entered the queue with gut-busting fundraising targets.